Impact of lupus susceptibility loci on peripheral tolerance and onset of disease

狼疮易感位点对外周耐受性和疾病发作的影响

基本信息

  • 批准号:
    7669145
  • 负责人:
  • 金额:
    $ 7.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-01 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The hallmark of autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) is the production of antibodies that bind to normal tissues (autoantibodies) and, as a result are deposited in multiple organ systems in the body, resulting in inflammation and tissue destruction. Although healthy individuals have the potential to produce autoantibodies, they do not, suggesting that autoantibody producing cells are silenced by a mechanism called tolerance. Most of our understanding of the pathogenesis of autoimmune diseases such as SLE to date has come from the studies of animal models. One such model is the hybrid mouse of New Zealand Black (NZB) x White (NZW) which develop a disease that resembles human SLE. Multiple genes contribute to the pathogenesis of autoimmune diseases such as SLE in humans. Likewise, three major regions of the genome (named Sle1, Sle2 and Sle3/Sle5) containing the genes that contribute to the disease process were identified in this SLE mouse model. Mice containing each of these genomic intervals give rise to different component phenotypes (manifestations) such as autoantibody production, kidney pathology etc., while their interaction culminates in full-blown SLE. It is not well understood how these lupus susceptibility genes are altering B cell tolerance, allowing autoantibody production. Using mouse models producing a high frequency of defined, autoreactive B cells, in the current grant application we propose to study how each of these lupus susceptibility loci influence B cell tolerance and autoantibody production leading to the development of autoimmune disease SLE. This will allow us to identify the defective tolerance processes causing the disease. Subsequently, once the genes in these genomic intervals are identified, we can study how the products of these genes specifically alter the functioning of the identified B cell tolerance processes. Such a mechanistic understanding will allow novel diagnostic and therapeutic approaches for systemic autoimmune diseases to be developed.
描述(由申请人提供): 系统性红斑狼疮(SLE)和类风湿性关节炎(RA)等自身免疫性疾病的特征是产生与正常组织结合的抗体(自身抗体),结果是沉积在体内的多个器官系统,导致炎症和组织破坏。尽管健康的人有产生自身抗体的潜力,但他们没有,这表明产生自身抗体的细胞被一种称为耐受的机制所抑制。到目前为止,我们对自身免疫性疾病(如SLE)发病机制的大部分了解都来自于动物模型的研究。其中一个这样的模型是新西兰黑(NZB)×白(NZW)的杂交小鼠,它会患上一种类似人类SLE的疾病。多基因参与了自身免疫性疾病的发病机制,如人类系统性红斑狼疮。 同样,在这个SLE小鼠模型中,发现了基因组的三个主要区域(命名为Sle1、Sle2和Sle3/Sle5),其中包含与疾病过程有关的基因。含有这些基因组间隔的小鼠会产生不同的成分表型(表现),如自身抗体产生、肾脏病理等,而它们的相互作用最终会导致完全发展的系统性红斑狼疮。目前还不清楚这些狼疮易感基因如何改变B细胞的耐受性,从而允许自身抗体的产生。利用产生高频率定义的、自身反应性B细胞的小鼠模型,在当前的赠款申请中,我们建议研究这些狼疮易感基因座如何影响B细胞耐受性和自身抗体的产生,从而导致自身免疫性疾病SLE的发展。这将使我们能够识别导致疾病的有缺陷的耐受过程。随后,一旦确定了这些基因组区间中的基因,我们就可以研究这些基因的产物如何特异性地改变已识别的B细胞耐受过程的功能。这种机械性的理解将使系统性自身免疫性疾病的新诊断和治疗方法得以开发。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ziaur Rahman其他文献

Ziaur Rahman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ziaur Rahman', 18)}}的其他基金

miR-21 regulation of autoreactive B cell and lupus nephritis development
miR-21对自身反应性B细胞和狼疮性肾炎发展的调节
  • 批准号:
    10888833
  • 财政年份:
    2022
  • 资助金额:
    $ 7.73万
  • 项目类别:
IRF7-mediated development of autoreactive B cells and SLE
IRF7 介导的自身反应性 B 细胞和 SLE 的发育
  • 批准号:
    10888832
  • 财政年份:
    2021
  • 资助金额:
    $ 7.73万
  • 项目类别:
IRF7-mediated development of autoreactive B cells and SLE
IRF7 介导的自身反应性 B 细胞和 SLE 的发育
  • 批准号:
    10277067
  • 财政年份:
    2021
  • 资助金额:
    $ 7.73万
  • 项目类别:
IRF7-mediated development of autoreactive B cells and SLE
IRF7 介导的自身反应性 B 细胞和 SLE 的发育
  • 批准号:
    10437008
  • 财政年份:
    2021
  • 资助金额:
    $ 7.73万
  • 项目类别:
"Perturbation of peripheral B cell tolerance by the lupus susceptibility loci"
“狼疮易感位点对外周 B 细胞耐受性的干扰”
  • 批准号:
    8507140
  • 财政年份:
    2011
  • 资助金额:
    $ 7.73万
  • 项目类别:
"Perturbation of peripheral B cell tolerance by the lupus susceptibility loci"
“狼疮易感位点对外周 B 细胞耐受性的干扰”
  • 批准号:
    8704864
  • 财政年份:
    2011
  • 资助金额:
    $ 7.73万
  • 项目类别:
"Perturbation of peripheral B cell tolerance by the lupus susceptibility loci"
“狼疮易感位点对外周 B 细胞耐受性的干扰”
  • 批准号:
    8564791
  • 财政年份:
    2011
  • 资助金额:
    $ 7.73万
  • 项目类别:
"Perturbation of peripheral B cell tolerance by the lupus susceptibility loci"
“狼疮易感位点对外周 B 细胞耐受性的干扰”
  • 批准号:
    8183980
  • 财政年份:
    2011
  • 资助金额:
    $ 7.73万
  • 项目类别:
"Perturbation of peripheral B cell tolerance by the lupus susceptibility loci"
“狼疮易感位点对外周 B 细胞耐受性的干扰”
  • 批准号:
    8318614
  • 财政年份:
    2011
  • 资助金额:
    $ 7.73万
  • 项目类别:
Impact of lupus susceptibility loci on peripheral tolerance and onset of disease
狼疮易感位点对外周耐受性和疾病发作的影响
  • 批准号:
    7846768
  • 财政年份:
    2008
  • 资助金额:
    $ 7.73万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 7.73万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 7.73万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 7.73万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 7.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了